Bromfenac Sodium is Used for managing ocular inflammation, postoperative inflammation, and reducing ocular pain in patients after cataract surgery. It was first introduced by Bausch And Lomb Inc in its drug Xibrom on Mar 24, 2005. Other drugs containing Bromfenac Sodium are Prolensa, Bromday, Bromsite. 13 different companies have introduced drugs containing Bromfenac Sodium.

Bromfenac Sodium Patents

Given below is the list of patents protecting Bromfenac Sodium, along with the drug name that holds that patent and the company name owning that drug.

Drug Used in	Drug Patent Number	Drug Patent Title	Drug Patent Expiry	Drug Owner
Bromsite	US8778999	Non-steroidal anti-inflammatory ophthalmic compositions	Aug 07, 2029	Sun Pharm
Prolensa	US10085958	Bromfenac bioavailability	Nov 19, 2032	Bausch And Lomb
Prolensa	US8129431	Aqueous liquid preparation containing 2-amino-3-(4-bromobenzoyl)phenylacetic acid	Sep 11, 2025	Bausch And Lomb
Prolensa	US8669290	Aqueous liquid preparation containing 2-amino-3-(4-bromobenzoyl)phenylacetic acid	Jan 16, 2024 (Expired)	Bausch And Lomb
Prolensa	US8754131	Aqueous liquid preparation containing 2-amino-3-(4-bromobenzoyl)phenylacetic acid	Jan 16, 2024 (Expired)	Bausch And Lomb
Prolensa	US8871813	Aqueous liquid preparation containing 2-amino-3-(4-bromobenzoyl)phenylacetic acid	Jan 16, 2024 (Expired)	Bausch And Lomb
Prolensa	US8927606	Aqueous liquid preparation containing 2-amino-3-(4-bromobenzoyl)phenylacetic acid	Jan 16, 2024 (Expired)	Bausch And Lomb
Prolensa	US9144609	Aqueous liquid preparation containing 2-amino-3-(4-bromobenzoyl)phenylacetic acid	Jan 16, 2024 (Expired)	Bausch And Lomb
Prolensa	US9517220	Bromfenac bioavailability	Nov 11, 2033	Bausch And Lomb
Prolensa	US9561277	Aqueous liquid preparation containing 2-amino-3-(4-bromobenzoyl)phenylacetic acid	Jan 16, 2024 (Expired)	Bausch And Lomb

Add above patents to watchlist

A patent's expiry date may change depending upon legal activities going on that patent. Critical activities like abandoning of a patent, term extension of a patent or amendment of its claims can increase or decrease the life of a patent hence affecting its expiry date and in turn affecting the generic launch date of that drug. Tracking these ongoing activities on a patent application helps to keep an eye on the latest developments in the patent process of the drug which can give an idea of how early a drug's generic could be available. The next section provides a list of recent legal activities on Bromfenac Sodium's patents.

Latest Legal Activities on Bromfenac Sodium's Patents

Given below is the list recent legal activities going on the following patents of Bromfenac Sodium.

Event	Date	Patent/Publication
Legal Activities This Week
Payment of Maintenance Fee, 8th Year, Large Entity	22 May, 2024	US9517220
Payment of Maintenance Fee, 8th Year, Large Entity	22 Mar, 2023	US9144609(Litigated)
Payment of Maintenance Fee, 8th Year, Large Entity	13 Jun, 2022	US8927606
Payment of Maintenance Fee, 4th Year, Large Entity	30 Mar, 2022	US10085958
Payment of Maintenance Fee, 8th Year, Large Entity	14 Mar, 2022	US8871813
Payment of Maintenance Fee, 8th Year, Large Entity	01 Dec, 2021	US8754131(Litigated)
Correspondence Address Change	30 Aug, 2021	US10085958
Correspondence Address Change	30 Aug, 2021	US9517220
Payment of Maintenance Fee, 8th Year, Large Entity	06 Aug, 2021	US8669290
Payment of Maintenance Fee, 4th Year, Large Entity	04 Jun, 2020	US9517220

Coming Soon

Patent Strength Analyzer

Will this be useful for you?

YesNo

Thank you for your response 🥳